Coronary Artery Calcium Score and Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia Patients Undergoing Standard Lipid Lowering Therapy

被引：0
|
作者：
Miname, Marcio [1 ]
Bittencourt, Marcio S. [2 ]
Moraes, Sergio R. [1 ]
Alves, Romulo, I [1 ]
Silva, Pamela R. [1 ]
Jannes, Cinthia E. [1 ]
Pereira, Alexandre C. [1 ]
Nasir, Khurram [3 ]
Santos, Raul D. [1 ]
机构：
[1] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil
[2] FICSAE, Med, Sao Paulo, Brazil
[3] Yale Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Calcification; Lipids;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11937
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy
    Miname, Marcio H.
    Bittencourt, Marcio Sommer
    Moraes, Sergio R.
    Alves, Romulo I. M.
    Silva, Pamela R. S.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Krieger, Jose E.
    Nasir, Khurram
    Santos, Raul D.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (09) : 1797 - 1804
  • [2] CORONARY ARTERY CALCIUM IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA RECEIVING STANDARD LIPID-LOWERING THERAPY
    Sheth, Samip
    Rader, Daniel
    Jacoby, Douglas
    CLINICAL CARDIOLOGY, 2019, 42 : S39 - S39
  • [3] LIPID LOWERING THERAPY WITH STATINS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V. A.
    Kuznetsova, T. Yu
    Tihova, G. P.
    KARDIOLOGIYA, 2019, 59 (03) : 27 - 35
  • [4] ADHERENCE TO LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V.
    Kuznetsova, T.
    ATHEROSCLEROSIS, 2018, 275 : E174 - E175
  • [5] Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia
    Cefalu, Angelo Baldassare
    Nardi, Emilio
    Giammanco, Antonina
    Gagliardo, Carola Maria
    Barbagallo, Carlo Maria
    La Grutta, Ludovico
    Toia, Patrizia
    Brucato, Federica
    Scrimali, Chiara
    Fasciana, Teresa Maria Grazia
    Spina, Rossella
    Lanza, Marina
    Vitale, Francesco
    Noto, Davide
    Averna, Maurizio
    LIFE-BASEL, 2025, 15 (03):
  • [6] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [7] The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia
    Gallo, Antonio
    Perez de Isla, Leopoldo
    Charriere, Sybil
    Vimont, Alexandre
    Alonso, Rodrigo
    Muniz-Grijalvo, Ovidio
    Diaz-Diaz, Jose L.
    Zambon, Daniel
    Moulin, Philippe
    Bruckert, Eric
    Mata, Pedro
    Beliard, Sophie
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (12) : 2414 - 2424
  • [8] Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment
    Miname, Marcio H.
    Bittencourt, Marcio S.
    Nasir, Khurram
    Santos, Raul D.
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (02) : 82 - 87
  • [9] IMPACT OF CORONARY ARTERY CALCIUM ON THE PROGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Tada, H.
    Nohara, A.
    Kawashiri, M. -A.
    Takamura, M.
    ATHEROSCLEROSIS, 2023, 379
  • [10] Regression of tendon xanthomata after lipid lowering therapy in patients with heterozygous familial hypercholesterolemia
    Kolovou, G
    Hatzaki, A
    Kafaltis, N
    Hoursalas, J
    Adamopoulou, E
    Mastorakou, I
    Aggelakas, S
    Cokkinos, DV
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 57 - 57
12345